$KARX
Karbon-X Corp.

2023 Q2 Form 10-K Financial Statement

#000147793223006860 Filed on September 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 2022 Q2
Revenue $2.010K $9.833K $0.00
YoY Change
Cost Of Revenue -$170.00 $1.025K $0.00
YoY Change
Gross Profit $2.180K $8.808K $0.00
YoY Change
Gross Profit Margin 108.46% 89.58%
Selling, General & Admin $1.357M $1.718M
YoY Change
% of Gross Profit 62250.0% 19508.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $400.00 $1.219K
YoY Change
% of Gross Profit 18.35% 13.84%
Operating Expenses $1.323M $1.990M $204.0K
YoY Change 548.75% 733.45% 7655.13%
Operating Profit -$1.321M -$1.981M -$204.0K
YoY Change 547.69% 729.76%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$20.82K -$6.855K $0.00
YoY Change
Pretax Income -$1.342M -$1.988M -$204.0K
YoY Change 557.89% 732.62% 7655.13%
Income Tax
% Of Pretax Income
Net Earnings -$1.342M -$1.997M -$204.0K
YoY Change 557.89% 736.51% 7655.13%
Net Earnings / Revenue -66758.21% -20310.54%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.02 -$0.03 -$3.131K
COMMON SHARES
Basic Shares Outstanding 70.04M shares 68.32M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $206.8K $477.3K
YoY Change -56.67% 136282.86%
Cash & Equivalents $206.8K $477.3K
Short-Term Investments
Other Short-Term Assets $59.77K $179.6K
YoY Change -66.72% 797.95%
Inventory $80.75K
Prepaid Expenses $59.77K $179.6K
Receivables
Other Receivables
Total Short-Term Assets $312.2K $667.7K
YoY Change -53.25% 3180.92%
LONG-TERM ASSETS
Property, Plant & Equipment $9.116K $3.254K
YoY Change 180.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.514M
YoY Change
Other Assets $88.27K $610.00
YoY Change 14370.49%
Total Long-Term Assets $2.203M $3.867K
YoY Change 56867.73% -193450.0%
TOTAL ASSETS
Total Short-Term Assets $312.2K $667.7K
Total Long-Term Assets $2.203M $3.867K
Total Assets $2.515M $671.6K
YoY Change 274.5% 3200.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $69.73K $30.75K
YoY Change 126.74% 631.19%
Accrued Expenses $24.75K $2.980K
YoY Change 730.54%
Deferred Revenue
YoY Change
Short-Term Debt $100.0K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $194.5K $33.73K
YoY Change 476.58% -60.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $55.42K
YoY Change
Total Long-Term Liabilities $55.42K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $194.5K $33.73K
Total Long-Term Liabilities $55.42K $0.00
Total Liabilities $249.9K $33.73K
YoY Change 640.87% -60.6%
SHAREHOLDERS EQUITY
Retained Earnings -$2.192M -$204.2K
YoY Change 973.36% 142.72%
Common Stock $72.58K $68.32K
YoY Change 6.23% 5.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.265M $637.9K
YoY Change
Total Liabilities & Shareholders Equity $2.515M $671.6K
YoY Change 274.5% 3199.92%

Cashflow Statement

Concept 2023 Q2 2023 2022 Q2
OPERATING ACTIVITIES
Net Income -$1.342M -$1.997M -$204.0K
YoY Change 557.89% 736.51% 7655.13%
Depreciation, Depletion And Amortization $400.00 $1.219K
YoY Change
Cash From Operating Activities -$612.2K -$1.485M -$361.5K
YoY Change 69.35% 310.96% 1204900.0%
INVESTING ACTIVITIES
Capital Expenditures $69.83K $7.058K -$3.250K
YoY Change -2248.62% 116.9%
Acquisitions
YoY Change
Other Investing Activities -$397.5K -$397.5K
YoY Change
Cash From Investing Activities -$467.4K -$750.6K -$3.250K
YoY Change 14280.31% 22966.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $180.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.176M $1.956M 855.0K
YoY Change 37.59% 128.77%
NET CHANGE
Cash From Operating Activities -612.2K -$1.485M -361.5K
Cash From Investing Activities -467.4K -$750.6K -3.250K
Cash From Financing Activities 1.176M $1.956M 855.0K
Net Change In Cash 96.82K -$270.5K 490.3K
YoY Change -80.25% -156.67% -1634266.67%
FREE CASH FLOW
Cash From Operating Activities -$612.2K -$1.485M -$361.5K
Capital Expenditures $69.83K $7.058K -$3.250K
Free Cash Flow -$682.0K -$1.492M -$358.3K
YoY Change 90.38% 309.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
477339 usd
CY2023Q2 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
522771 usd
CY2022Q2 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
176777 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001729637
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
0 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73540000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68320000 shares
CY2023 karx Exercised
Exercised
0 shares
CY2023 karx Expired
Expired
0 shares
CY2023 karx Cancelled
Cancelled
0 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice
0
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-05-31
CY2023 dei Entity File Number
EntityFileNumber
000-56288
CY2023 dei Entity Registrant Name
EntityRegistrantName
Karbon-X Corp.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-2882342
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
910 7th Ave SW
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Calgary
CY2023 dei Entity Address Country
EntityAddressCountry
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
T2P 3N8
CY2023 dei City Area Code
CityAreaCode
844
CY2023 dei Local Phone Number
LocalPhoneNumber
462-3637
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
72579000 shares
CY2023 dei Auditor Name
AuditorName
Fruci & Associates II, PLLC
CY2023 dei Auditor Firm
AuditorFirmId
5525
CY2023 dei Auditor Location
AuditorLocation
Spokane, Washington
CY2023Q2 karx Amounts Due To Related Parties Current
AmountsDueToRelatedPartiesCurrent
0 usd
CY2022Q2 karx Amounts Due To Related Parties Current
AmountsDueToRelatedPartiesCurrent
0 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
55415 usd
CY2022Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 usd
CY2023 us-gaap Other General Expense
OtherGeneralExpense
271519 usd
CY2022 us-gaap Other General Expense
OtherGeneralExpense
104743 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-1987877 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-238745 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
9258 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-13044 usd
CY2022 karx Recap Of Cocoluv Inc Amount
RecapOfCocoluvIncAmount
34658 usd
CY2022 karx Issuance Of Shares And Warrants For Cash Amount
IssuanceOfSharesAndWarrantsForCashAmount
855000 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-13044 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-234746 usd
CY2023 karx Shares To Be Issued For Stock Compensation
SharesToBeIssuedForStockCompensation
625000 usd
CY2023 karx Issuance Of Shares And Warrants For Cash Amount
IssuanceOfSharesAndWarrantsForCashAmount
1855969 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
9258 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1997135 usd
CY2023 karx Income Loss Net
IncomeLossNet
-1997135 usd
CY2022 karx Income Loss Net
IncomeLossNet
-238745 usd
CY2023 karx Recap Of Cocoluv Inc
RecapOfCocoluvInc
0 usd
CY2022 karx Recap Of Cocoluv Inc
RecapOfCocoluvInc
34658 usd
CY2023 us-gaap Depreciation
Depreciation
1219 usd
CY2022 us-gaap Depreciation
Depreciation
0 usd
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
8039 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2023 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3177 usd
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
625000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-34777 usd
CY2022 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-10809 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
38979 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
30754 usd
CY2023 us-gaap Increase Decrease In Trading Liabilities
IncreaseDecreaseInTradingLiabilities
7084 usd
CY2022 us-gaap Increase Decrease In Trading Liabilities
IncreaseDecreaseInTradingLiabilities
2976 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-80750 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2808 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
1205 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
0 usd
CY2023 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-6903 usd
CY2022 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-613 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1485069 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-184587 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7058 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3253 usd
CY2023 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
397523 usd
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
CY2023 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
345994 usd
CY2022 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
176777 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-750575 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-180030 usd
CY2023 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
100000 usd
CY2022 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2023 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1855969 usd
CY2022 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
855000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1955969 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
855000 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9155 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-13044 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-270520 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
477339 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
477339 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
206820 usd
CY2023 karx Capitalization Of Right Of Use Asset
CapitalizationOfRightOfUseAsset
-71425 usd
CY2022 karx Capitalization Of Right Of Use Asset
CapitalizationOfRightOfUseAsset
0 usd
CY2023 karx Capitalization Of Lease Liability
CapitalizationOfLeaseLiability
-68920 usd
CY2022 karx Capitalization Of Lease Liability
CapitalizationOfLeaseLiability
0 usd
CY2023 karx Non Cash Paymentrecapofcocoluvinc
NonCashPaymentrecapofcocoluvinc
0 usd
CY2022 karx Non Cash Paymentrecapofcocoluvinc
NonCashPaymentrecapofcocoluvinc
34658 usd
CY2023 us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
1219 usd
CY2022 us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
0 usd
CY2023 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
8039 usd
CY2022 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
0 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3177 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
625000 usd
CY2022 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
0 usd
CY2023 karx Shares To Be Issued For The Silviculture Investment
SharesToBeIssuedForTheSilvicultureInvestment
1125000 usd
CY2022 karx Shares To Be Issued For The Silviculture Investment
SharesToBeIssuedForTheSilvicultureInvestment
0 usd
CY2023 karx Shares To Be Issued As Stock Based Compensation
SharesToBeIssuedAsStockBasedCompensation
625000 usd
CY2022 karx Shares To Be Issued As Stock Based Compensation
SharesToBeIssuedAsStockBasedCompensation
0 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 karx Issued And Outstanding Shares Of Common Stock Converted Exchange Ratio Description
IssuedAndOutstandingSharesOfCommonStockConvertedExchangeRatioDescription
20,000-for-1
CY2023Q2 karx Shares Authorized
SharesAuthorized
20000000 shares
CY2023Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
134 usd
CY2023Q2 karx Related Party Transaction Amounts Due From To Related Party
RelatedPartyTransactionAmountsDueFromToRelatedParty
99902 usd
CY2023 us-gaap Other Operating Income
OtherOperatingIncome
2192106 usd
CY2023 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
15992 usd
CY2022 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
305 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Accordingly, actual results could differ from those estimates. </p>
CY2023 karx Significant Estimates
SignificantEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant estimates applied in the preparation of these financial statements include the estimated useful lives of property and equipment, share volatility and estimated life of options and warrants in determining their fair value as well as the expected potential for the realization of deferred tax assets in determining the amount of the valuation allowance thereto.</p>
CY2023Q2 karx Prepaid Accounting Services Current
PrepaidAccountingServicesCurrent
0 usd
CY2022Q2 karx Prepaid Accounting Services Current
PrepaidAccountingServicesCurrent
2544 usd
CY2023Q2 karx Prepaid Inventory Net
PrepaidInventoryNet
59767 usd
CY2022Q2 karx Prepaid Inventory Net
PrepaidInventoryNet
0 usd
CY2023Q2 karx Prepaid Furniture Expenses Current
PrepaidFurnitureExpensesCurrent
0 usd
CY2022Q2 karx Prepaid Furniture Expenses Current
PrepaidFurnitureExpensesCurrent
264 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
59767 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2808 usd
CY2023Q2 karx Carbon Credit Inventory Amount
CarbonCreditInventoryAmount
80750 usd
CY2022Q2 karx Carbon Credit Inventory Amount
CarbonCreditInventoryAmount
0 usd
CY2023Q2 us-gaap Other Inventory
OtherInventory
80750 usd
CY2022Q2 us-gaap Other Inventory
OtherInventory
0 usd
CY2023 karx Office Chairs Purchase
OfficeChairsPurchase
3353 usd
CY2023 karx Computers Purchase
ComputersPurchase
3705 usd
CY2023 us-gaap Depreciation
Depreciation
1219 usd
CY2023 karx Statement Of Stockholders Equity
StatementOfStockholdersEquity
During the year ended May 31, 2023, the Company executed an agreement to issue shares of Karbon-X Corp for the purchase of up to 80% of Silviculture Systems to be issued in tranches based on completion of milestones. As of May 31, 2023, the Company has purchased 24% of Silviculture Systems for 4,500,000 shares of Karbon-X Corp shown as shares to be issued for a value of $1,125,000
CY2023 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
2500000 shares
CY2023Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.25
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
625000 usd
CY2022 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
3420000 shares
CY2022 karx Stock Option Exercise Price
StockOptionExercisePrice
0.25
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
855000 usd
CY2022 karx Share Of Common Stock In Warrant Desription
ShareOfCommonStockInWarrantDesription
Each unit consisted of share of common stock and warrant to purchase a share of common stock for $0.75 per share for a period of two years
CY2022 karx Compensation Given To Business Transaction
CompensationGivenToBusinessTransaction
10000 usd
CY2023Q2 karx Warrants Issued
WarrantsIssued
720000 shares
CY2023 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0.75
CY2023 karx Value Of Warrants
ValueOfWarrants
180000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3420000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.75
CY2023 karx Weighted Average Remaining Contractual Life In Years Beginning Balance
WeightedAverageRemainingContractualLifeInYearsBeginningBalance
P0Y9M7D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
720000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.75
CY2023 karx Weighted Average Remaining Contractual Life In Years Granted
WeightedAverageRemainingContractualLifeInYearsGranted
P1Y18D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4140000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.75
CY2023 karx Weighted Average Remaining Contractual Life In Years Ending Balance
WeightedAverageRemainingContractualLifeInYearsEndingBalance
P0Y9M29D
CY2023 karx Share Exchange Agreement
ShareExchangeAgreement
0.80 pure
CY2023 karx Share Exchange Agreement Value
ShareExchangeAgreementValue
7250000 usd
CY2023Q2 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
522771 usd
CY2022Q2 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
176777 usd
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
100000 usd
CY2023 us-gaap Subordinated Borrowing Interest Rate
SubordinatedBorrowingInterestRate
0.08 pure
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
21472 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
28630 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
28630 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
4772 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
0 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
83504 usd
CY2023Q2 karx Less Imputed Interest
LessImputedInterest
-13401 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
70103 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14688 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
55415 usd
CY2023 us-gaap Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate
FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate
0.1025 pure
CY2023 karx Weighted Average Remaining Lease Term Years
WeightedAverageRemainingLeaseTermYears
P3Y2M1D

Files In Submission

Name View Source Status
0001477932-23-006860-index-headers.html Edgar Link pending
0001477932-23-006860-index.html Edgar Link pending
0001477932-23-006860.txt Edgar Link pending
0001477932-23-006860-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
karx-20230531.xsd Edgar Link pending
karx_10k.htm Edgar Link pending
karx_10kimg2.jpg Edgar Link pending
karx_10kimg3.jpg Edgar Link pending
karx_ex105.htm Edgar Link pending
karx_ex21.htm Edgar Link pending
karx_ex311.htm Edgar Link pending
karx_ex312.htm Edgar Link pending
karx_ex321.htm Edgar Link pending
karx_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
karx_10k_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
karx-20230531_cal.xml Edgar Link unprocessable
karx-20230531_def.xml Edgar Link unprocessable
karx-20230531_pre.xml Edgar Link unprocessable
karx-20230531_lab.xml Edgar Link unprocessable